News Focus
News Focus
Followers 24
Posts 820
Boards Moderated 0
Alias Born 04/15/2007

Re: None

Sunday, 05/02/2021 8:29:49 PM

Sunday, May 02, 2021 8:29:49 PM

Post# of 84811
In addition to the European patent office intentions to approve the cv-007 patent this initial publication of a cv-007 study in the european journal Psychopharmacology should be another PR.

https://link.springer.com/article/10.1007/s00213-021-05845-4

Funding suggest that money is available for cvsi to pursue this program.

"This work was supported by the National Institute on Drug Abuse (grant no. 1F31DA047113-01 to L.C.S.), National Institute on Alcohol Abuse and Alcoholism (grant no. AA022977 and AA006420 to O.G.), Tobacco-Related Disease Research Program (grant no. 27IR-0047 to O.G.), Tobacco-Related Disease Research Program (grant no. T31KT1859 to M.K.), and CV science (O.G.)."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News